Search Within

Eli Louis Diamond

  1. "2022"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (7)
  3. Guidelines (1)
  4. Miscellaneous (1)
  5. Review (1)
Groups
  1. Population Sciences Research Program (8)
  2. Psychiatry Service (6)
  3. Psychiatry and Behavioral Sciences, Department of (6)
  4. Department of Medicine (5)
  5. Biostatistics Service (4)
  6. Department of Pathology and Laboratory Medicine (4)

More Groups

People
  1. Allison Applebaum (6)
  2. Benjamin Durham (5)
  3. Anne Reiner (4)
  4. Katherine Panageas (4)
  5. Kathleen Lynch (4)
  6. Laura Polacek (4)

More People

Years
  1. 2022 (18)
Publications
  1. Blood (3)
  2. Journal of Clinical Oncology (2)
  3. Psycho-Oncology (2)
  4. JAMA Ophthalmology (1)
  5. JNCI Cancer Spectrum (1)
  6. Journal of Neuro-Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (3)
  2. American Society of Clinical Oncology (2)
  3. John Wiley & Sons (2)
  4. Oxford University Press (2)
  5. Springer (2)
  6. American Medical Association (1)

More Publishers

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ALK-positive histiocytosis: A new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
    Journal Article

    Kemps, P. G.; Picarsic, J.; Durham, B. H.; HeĢlias-Rodzewicz, Z.; Hiemcke-Jiwa, L.; van den Bos, C.; van de Wetering, M. D.; van Noesel, C. J. M.; van Laar, J. A. M.; Verdijk, R. M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • RAF-Independent MEK mutations drive histiocytic neoplasms in vivo and are sensitive to single-agent ERK inhibition in patients
    Meeting Abstract

    Durham, B. H.; Singer, M. E.; Benbarche, S.; Erickson, C.; Rahman, J.; Solit, D. B.; Witkowski, M.; Rosen, N.; Abdel-Wahab, O.; Diamond, E. L.
    Blood (2022)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Yabe, M.; Petrova-Drus, K.; Rosenblum, M.; Rotemberg, V.; Lacouture, M. E.; Rampal, R.; Francis, J.; Knoerzer, D.; Kreider, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Overcoming barriers to tumor genomic profiling through direct patient social media outreach
    Meeting Abstract

    Doe-Tetteh, S. A.; Camp, S. Y.; Crowdis, J.; Noronha, A. M.; Reales, D.; Alano, T.; Viale, A.; Donoghue, M.; Socci, N. D.; Berger, M. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Treatment-refractory nodular scleritis
    Miscellaneous

    Francis, J. H.; Gobin, Y. P.; Diamond, E. L.
    JAMA Ophthalmology (2022)

    Fulltext@MSK | Save
  • A qualitative exploration of the feasibility and acceptability of Meaning-Centered Psychotherapy for Cancer Caregivers
    Journal Article

    Applebaum, A. J.; Roberts, K. E.; Lynch, K.; Gebert, R.; Loschiavo, M.; Behrens, M.; Walsh, L. E.; Polacek, L. C.; Diamond, E. L.; Breitbart, W. S.
    Palliative and Supportive Care (2022)

    Fulltext@MSK | Save
  • Meaning-Centered Psychotherapy for Cancer Caregivers: A pilot trial among caregivers of patients with glioblastoma multiforme
    Journal Article

    Applebaum, A. J.; Baser, R. E.; Roberts, K. E.; Lynch, K.; Gebert, R.; Breitbart, W. S.; Diamond, E. L.
    Translational Behavioral Medicine (2022)

    Fulltext@MSK | Save
  • Challenges and positive impact of rare cancer caregiving: A mixed-methods study of caregivers of patients with Erdheim-Chester disease and other histiocytic neoplasms: Challenges and positive impact in histiocytic neoplasm caregivers
    Journal Article

    Mitchell, H. R.; Applebaum, A. J.; Lynch, K. A.; Reiner, A. S.; Atkinson, T. M.; Buthorn, J. J.; Sigler, A. S.; Bossert, D.; Brewer, K.; Corkran, J.; more...
    eClinicalMedicine (2022)

    Fulltext@MSK | Save
  • Phase I study of concurrent paxalisib and radiation therapy in patients with solid tumor brain metastases or leptomeningeal metastases harboring PI3K pathway mutations: Results from the dose-escalation cohort
    Meeting Abstract

    Yang, J.; Mann, J.; Pike, L.; Zinovoy, M.; Young, R.; Offin, M.; Mitchell, R.; Kazarian, A.; Shadat, T.; Garner, J.; more...
    Neuro-Oncology Advances (2022)

    Fulltext@MSK | Save
  • Coping with glioblastoma: Prognostic communication and prognostic understanding among patients with recurrent glioblastoma, caregivers, and oncologists
    Journal Article

    Walsh, L. E.; Polacek, L. C.; Panageas, K.; Reiner, A.; Walbert, T.; Thomas, A. A.; Buthorn, J.; Sigler, A.; Prigerson, H. G.; Applebaum, A. J.; more...
    Journal of Neuro-Oncology (2022)

    Fulltext@MSK | Save